Earnings Report /Singapore
Hyphens Pharma International Ltd: Digital healthcare catalyst emerges
Raised $6mn for a 10% stake in Hyphens Pharma digital assets – DocMed Technology
DocMed Technology owns POM (B2B digital hypermart) and WellAway (Singapore’s first and only HSA registered e-pharmacy).
Our DCF target price is raised from S$0.345 to S$0.43